Scientists suggest that the BPC157 can be effective to cellular repair by growth factors, but the majority of studies are still in their infancy
Suzanne Somers: this is sounding like gobbly-gook
BPC-157: Continue 250-500 mcg twice daily Cryotherapy: Once daily post-activity application Introduce progressive loading appropriate to the injury type Monitor for signs of excessive inflammation (increased pain, swelling, heat) Chronic Condition Management Sustained approach for arthritis, chronic tendinopathy, or recurring injuries
Combination therapies are also being explored, such as a phase II study combining semaglutide with the FXR agonist cilofexor and the ACC inhibitor firsocostat, which showed greater improvements in hepatic steatosis and metabolic biomarkers compared to semaglutide alone
Thiosulfate levels were also increased in the presence of 3MP in brain cells prepared from the wild-type mice compared to those from 3MST-KO mice (Supplementary Fig
IV and injectable NAD+ therapy may be considered as part of a longevity protocol after medical evaluation
